Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Plans to build a long-promised biological manufacturing facility in Manhattan have fizzled, though company leaders prefer not ...

Relay Therapeutics Inc. (NASDAQ:RLAY) is a leading clinical-stage precision medicines firm focused on cancer treatments. The ...

The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...

The company will acquire Scorpion's experimental oral therapy ... including increased competition in the Covid vaccine market, as the biotech company continues to slash costs. Eli Lilly on Tuesday cut ...

The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

The company will acquire Scorpion's experimental oral therapy ... including increased competition in the Covid vaccine market, as the biotech company continues to slash costs.

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...